After the sponsor halted the trial, despite the DSMB’s advice to continue, investigators aimed to salvage the scientific value.

CLEVELAND -- Whether vagal nerve stimulation improved outcomes for heart failure patients with reduced ejection fraction (HFrEF) remained unclear after ANTHEM-HFrEF was terminated early, with the ...

BioCardia ®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported the Consultation Record from ...

prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...

Please provide your email address to receive an email when new articles are posted on . Eplerenone was beneficial to patients regardless of how long they have had heart failure with reduced ejection ...

The FDA has approved empagliflozin (Jardiance) for adults with heart failure with reduced ejection fraction, regardless of type 2 diabetes status. The FDA has approved Boehringer Ingelheim and Eli ...

When the sympathetic nervous system is unregulated, it can lead to high blood pressure and elevated heart rate. The combination of sacubitril-valsartan, sold as Entresto, that is currently the only ...

Swedish investigators looked at potassium levels and all-cause mortality in HFrEF patients at 30 days, 12 months, and 5 years. Over all 3 time frames, the sweet spot in terms of lowest hazard risk for ...

Nine out of 10 hospitalized patients who have heart failure with reduced ejection fraction (HFrEF) may be potential candidates for the novel agent vericiguat (Merck Sharp & Dohme/Bayer) to lower their ...

Please provide your email address to receive an email when new articles are posted on . Women with HFrEF had a 72% lower rate of LVAD use vs. men. Black men had a 46% lower rate of heart transplant vs ...

The rest is history. So, in a way, ICDs for primary prevention of sudden cardiac death in patients with HFrEF is old news, as is cardiac resynchronization therapy for HFrEF if you have a wide QRS left ...

prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...